AzTrials
AzTrials

Jaw, EdentulousILICRANNCT02664298

Prospective Registry of Immediate/Delayed Loading of Implants in the Cranial Bone-grafted Severely Atrophic Jaw

An observational study of Jaw, Edentulous and Jaw, Partially Edentulous, run by AZ Sint-Jan AV at 1 site in Belgium.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Edentulism is often associated with a negative psychosocial impact. The concept of prosthetic rehabilitation in which a prosthesis is supported by osseointegrated implants, was first introduced in the late 1960s by Brånemark et al. and offers an interesting alternative to removable prosthesis. Read more about this study

Who is it for?
Any age
Conditions the study is for
Jaw, Edentulous, Jaw, Partially Edentulous
How many people
120 participants
Where
1 siteBelgium
Study dates
Jan 2007to Feb 2021
How long will I take part?
36 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: all consenting patients that require fixed prosthetic rehabilitation in a cranial bone-grafted severely atrophic jaw

Who may be able to join

  • Patients of all ages
  • Patients of all genders
  • Patients with moderate to extreme bone atrophy of the jaw (class IV to VI according to Cawood and Howell (Cawood \& Howell, 1988), caused by terminal periodontitis or edentulism
  • Patients requiring bone augmentation procedures through cranial bone grafting for jaw reconstruction
  • Patients ineligible for conventional removable prosthetic rehabilitation

Who cannot join

  • Patients not eligible according to abovementioned criteria
  • Patients with severe uncontrolled diabetes
  • Patients with cranial vault without diploe and/or cranial vault thickness <3mm, as defined with cone-beam CT (De Ceulaer, et al., 2012)

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Araceli Diez-Fraile

    Bruges, Other (Non U.s.), 8000

Other trials in Belgium

About this study

Edentulism is often associated with a negative psychosocial impact. The concept of prosthetic rehabilitation in which a prosthesis is supported by osseointegrated implants, was first introduced in the late 1960s by Brånemark et al. and offers an interesting alternative to removable prosthesis. However, for patients with a severely atrophic maxilla or mandible, cranial bone grafting of the jaw is required to increase bone width and height necessary for implant insertion. An active collaboration between the surgeons from the Oral and Maxillofacial Department and the prosthodontist from the Department of Dentistry has been established for continuous quality improvement of the concept of (immediate/delayed) implant loading in patients requiring cranial bone grafts to augment their severely atrophic jawbone.

The investigators aim to develop a prospective database registering (immediate/delayed) implant loading data of all patients eligible according to the protocol. Patient demographics, surgical, dental, prosthetic and patient satisfaction parameters are collected during consecutive visits within the framework of routine practice.

Development of a database registering immediate functional loading data secondary to cranial bone-grafting of a severely atrophic jaw, will provide more information about potential patient, surgical and prosthetic factors influencing long-term biological and mechanical stability, as well as patient satisfaction. Moreover, registration of those results could function as a measurement of quality of care, and could be used for sample size calculation for future large prospective trials.

Keywords
severely atrophic jaw, cranial bone-graft, dental implants, immediate loading, augmentation maxilla/mandible, sinus-floor elevation/sinuslift, dental prosthesis, implant supported, provisional implants, temporary implants, one-stage surgery, alveolar ridge augmentation, maxilla
Medical subject headings
Jaw, Edentulous, Jaw, Edentulous, Partially

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IPI survival rate at time of immediate loading in patients with cranial bone-grafted severely atrophic jaw

    Measured: within 6 months postsurgery

  2. definitive implant survival rate in patients with cranial bone-grafted severely atrophic jaw

    Measured: within 12 months postoperative

  3. bone-graft resorption, as evaluated through cone-beam computed tomography

    Measured: within 12 months postoperative

  4. prosthesis survival rate

    Measured: until a maximum of 10 years follow-up

  5. bone-graft resorption, as evaluated through cone-beam computed tomography

    Measured: until a maximum of 10 years follow-up

Secondary outcomes (2)
  1. Prevalence of patients with severely atrophic jaw requiring cranial bone-grafting

    Measured: every 12 months, until a maximum of ten years

  2. Potential biologic or mechanical risk factors that could predict undesirable functional or aesthetic outcome, through regression analysis

    Measured: within 12 months postsurgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2016 (estimated)
  2. Study startJan 2007
  3. Primary completionFeb 2021
  4. Study completionFeb 2021

Why it stopped: Registry of patients registry has been discontinued

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (actual)
Target duration
36 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT02664298
Sponsor's protocol ID
B049201525497
Acronym
ILICRAN
Status last verified
Feb 2022
First submitted
11 Jan 2016
Last updated
28 Feb 2022
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Jaw, Edentulous and Jaw, Partially Edentulous, run by AZ Sint-Jan AV at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Registry of patients registry has been discontinued). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IPI survival rate at time of immediate loading in patients with cranial bone-grafted severely atrophic jaw (time frame: within 6 months postsurgery). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in